Pathological Case of the Month | Coagulation Disorders | JAMA Pediatrics | JAMA Network
[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.153.39.7. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Special Feature
June 2001

Pathological Case of the Month

Arch Pediatr Adolesc Med. 2001;155(6):738. doi:10.1001/archpedi.155.6.737

Figure 1. Computed tomographic scan of the head shows a subcutaneous dense soft tissue massive lesion with calcification (hemangioma).

Figure 2. The section of subcutaneous lesion of the head reveals proliferation of endothelial-lined blood vessels separated by scanty stroma and areas of hemorrhage.

Figure 3. The section of the lung shows small vessels containing intravascular basophilic granular thrombi.

Figure 4. The section of the lung reveals positive immunohistochemical staining for platelet factor VIII of intravascular basophilic granular thrombi (platelet thrombi).

Microvascular platelet thrombosis is an uncommon condition. In several diseases, it is presumed to result in endothelial cell damage or dysfunction; intravascular coagulation plays an important pathogenic role. These disorders include thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. The features of this disorder are the apparent selective consumption of platelets, usually without accompanying coagulation abnormalities, and the predominance of platelets as the occlusive material in the microvessels.1 The organ systems with a high incidence of microvascular thrombosis associated with subsequent end-organ dysfunction include lungs, renal, central nervous system, liver, adrenal glands, and heart. Microvascular platelet thrombosis is often easily demonstrated in the pulmonary microcirculation, where it is customarily seen in association with intense vasoconstriction resulting from vasoconstrictive compounds released from platelets, including biogenic amines, adenine nucleotides, and kinins.2 The presence of platelet microthrombi is also an early finding in patients with disseminated intravascular coagulation. The early deposited platelet-rich microthrombi are later replaced by fibrin-rich hyaline microthrombi.3 The microscopic study of the lungs in our case showed the small vessels filled with platelet thrombi that were confirmed by factor VIII stain. Moreover, these thrombi were negative for fibrin stain. These observations suggest the possibility of selective consumption of platelet or early stage of disseminated intravascular coagulation. Several mechanisms of pathologic platelet aggregation have been proposed. The presence of a platelet-agglutinating protein in the plasma in the thrombotic thrombocytopenic purpura is postulated.4 On the other hand, von Willebrand factor multimers in the blood and their involvement in the excessive and inappropriate agglutination of platelets have been suggested.5 In our case, it is apparent that a multifactorial process resulted in the intraluminal platelet thrombus formation. The surgical resection of massive hemangioma may be associated with the release of platelet-agglutinating protein and/or von Willebrand factor multimers from damaged endothelial cells into the systemic circulation. It has been known that intravascular hemolysis of any origin is a common triggering event for disseminated intravascular coagulation. During hemolysis, the release of red blood cell adenosine diphosphate and/or red blood cell membrane phospholipoprotein may activate the procoagulant system.2,6

×